This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Innovations in Cancer Treatment by Rebecca D Riba
Introduction
Rebecca D Riba is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on utilizing vascular endothelial growth factor receptor 1+ cells to improve cancer therapies.
Latest Patents
Rebecca D Riba's latest patents include methods for inhibiting tumor formation and preventing metastases in cancer patients. These inventions involve administering inhibitors of vascular endothelial growth factor receptor 1 bone marrow-derived cells. The methods are designed to be effective in preventing tumor formation at sites remote from previous tumor locations. Additionally, her patents outline how to monitor metastases by evaluating patient samples for the detection and quantification of these specific cells.
Career Highlights
Rebecca D Riba is affiliated with Cornell University, where she conducts her research and develops her innovative ideas. Her work has garnered attention for its potential to change the landscape of cancer treatment and monitoring.
Collaborations
Some of her notable coworkers include Shahin Rafii and Rosandra N Kaplan, who contribute to her research efforts and advancements in the field.
Conclusion
Rebecca D Riba's contributions to cancer treatment through her patented inventions highlight her role as a leading innovator in the medical field. Her work continues to pave the way for new therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile